Search Results - Eva Corey

Refine Results
  1. 1

    Data of relative mRNA and protein abundances of androgen receptor splice variants in castration-resistant prostate cancer by Tianfang Ma, Nathan Ungerleider, Derek Y. Zhang, Eva Corey, Erik K. Flemington, Yan Dong

    Published in Data in Brief (2021-02-01)
    Get full text
    Article


  2. 2

    Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis by Siyuan Cheng, Lin Li, Yunshin Yeh, Yingli Shi, Omar Franco, Eva Corey, Xiuping Yu

    Published in npj Precision Oncology (2024-08-01)
    Get full text
    Article


  3. 3

    PlexinD1 is a driver and a therapeutic target in advanced prostate cancer by Jing Wei, Jing Wang, Wen Guan, Jingjing Li, Tianjie Pu, Eva Corey, Tzu-Ping Lin, Allen C Gao, Boyang Jason Wu

    Published in EMBO Molecular Medicine (2025-01-01)
    Get full text
    Article


  4. 4

    Inhibition of Androgen-Independent Prostate Cancer by Estrogenic Compounds Is Associated with Increased Expression of Immune-Related Genes by Ilsa M. Coleman, Jeffrey A. Kiefer, Lisha G. Brown, Tiffany E. Pitts, Peter S. Nelson, Kristen D. Brubaker, Robert L. Vessella, Eva Corey

    Get full text
    Article


  5. 5

    Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors by Xiong Zhang, Yatian Yang, Hongye Zou, Yang Yang, Xingling Zheng, Eva Corey, Amina Zoubeidi, Nicolas Mitsiades, Ai-Ming Yu, Yuanpei Li, Hong-Wu Chen

    Published in Acta Pharmaceutica Sinica B (2025-03-01)
    Get full text
    Article


  6. 6

    Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling. by Holly M Nguyen, Nazanin Ruppender, Xiaotun Zhang, Lisha G Brown, Ted S Gross, Colm Morrissey, Roman Gulati, Robert L Vessella, Frauke Schimmoller, Dana T Aftab, Eva Corey

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  7. 7

    HE3235 Inhibits Growth of Castration-Resistant Prostate Cancer by Theodore D. Koreckij, Richard J. Trauger, Robert Bruce Montgomery, Tiffany E.M. Pitts, Ilsa Coleman, Holly Nguyen, Chris L. Reading, Peter S. Nelson, Robert L. Vessella, Eva Corey

    Get full text
    Article


  8. 8

    Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells by Shiv Ram Krishn, Vaughn Garcia, Nicole M. Naranjo, Fabio Quaglia, Christopher D. Shields, Maisha A. Harris, Andrew V. Kossenkov, Qin Liu, Eva Corey, Dario C. Altieri, Lucia R. Languino

    Published in Cancer Biology & Therapy (2022-12-01)
    Get full text
    Article


  9. 9

    Alteration in expression and subcellular localization of the androgen receptor- regulated FAM111A protease is associated with emergence of castration resistant prostate cancer by Maria Malvina Tsamouri, Stephen J. Libertini, Salma Siddiqui, Maitreyee K. Jathal, Blythe P. Durbin-Johnson, Clifford G. Tepper, Eva Corey, Jun Luo, Kenneth A. Iczkowski, Paramita M. Ghosh, Maria Mudryj

    Get full text
    Article


  10. 10

    Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy. by Nazanin Ruppender, Sandy Larson, Bryce Lakely, Lori Kollath, Lisha Brown, Ilsa Coleman, Roger Coleman, Holly Nguyen, Peter S Nelson, Eva Corey, Linda A Snyder, Robert L Vessella, Colm Morrissey, Hung-Ming Lam

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  11. 11

    Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis. by Elahe A Mostaghel, Andrew Morgan, Xiaotun Zhang, Brett T Marck, Jing Xia, Rachel Hunter-Merrill, Roman Gulati, Stephen Plymate, Robert L Vessella, Eva Corey, Celestia S Higano, Alvin M Matsumoto, R Bruce Montgomery, Peter S Nelson

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  12. 12

    Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression. by Fabio Quaglia, Shiv Ram Krishn, Yanqing Wang, David W Goodrich, Peter McCue, Andrew V Kossenkov, Amy C Mandigo, Karen E Knudsen, Paul H Weinreb, Eva Corey, William K Kelly, Lucia R Languino

    Published in PLoS ONE (2021-01-01)
    Get full text
    Article


  13. 13

    Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth by Galina Gritsina, Ka-wing Fong, Xiaodong Lu, Zhuoyuan Lin, Wanqing Xie, Shivani Agarwal, Dong Lin, Gary E. Schiltz, Himisha Beltran, Eva Corey, Colm Morrissey, Yuzhuo Wang, Jonathan C. Zhao, Maha Hussain, Jindan Yu

    Published in The Journal of Clinical Investigation (2023-08-01)
    Get full text
    Article


  14. 14

    Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3′ untranslated region mutations by Samantha L. Schuster, Sonali Arora, Cynthia L. Wladyka, Pushpa Itagi, Lukas Corey, Dave Young, Bethany L. Stackhouse, Lori Kollath, Qian V. Wu, Eva Corey, Lawrence D. True, Gavin Ha, Patrick J. Paddison, Andrew C. Hsieh

    Published in Cell Reports (2023-08-01)
    Get full text
    Article


  15. 15

    Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress by Michael D. Nyquist, Alexandra Corella, Ilsa Coleman, Navonil De Sarkar, Arja Kaipainen, Gavin Ha, Roman Gulati, Lisa Ang, Payel Chatterjee, Jared Lucas, Colin Pritchard, Gail Risbridger, John Isaacs, Bruce Montgomery, Colm Morrissey, Eva Corey, Peter S. Nelson

    Published in Cell Reports (2020-05-01)
    Get full text
    Article


  16. 16

    LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer by Anbarasu Kumaraswamy, Rahul Mannan, Olivia A. Swaim, Eva Rodansky, Xiao-Ming Wang, Aaron Udager, Rohit Mehra, Hui Li, Colm Morrissey, Eva Corey, Michael C. Haffner, Peter S. Nelson, Arul M. Chinnaiyan, Joel A. Yates, Joshi J. Alumkal

    Get full text
    Article


  17. 17

    Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes by Shu Ning, Jinge Zhao, Alan P. Lombard, Leandro S. D’Abronzo, Amy R. Leslie, Masuda Sharifi, Wei Lou, Chengfei Liu, Joy C. Yang, Christopher P. Evans, Eva Corey, Hong-Wu Chen, Aiming Yu, Paramita M. Ghosh, Allen C. Gao

    Published in Communications Medicine (2022-09-01)
    Get full text
    Article


  18. 18

    Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancer by Ujjwal R. Dahiya, Sangeeta Kumari, Nidhi Singh, Chitra Rawat, Eduardo Cortes, Yara Ghanem, Eva Corey, Scott M. Dehm, Belinda Willard, Mohammed Alshalalfa, Elai Davicioni, Jesse McKenney, Christopher Weight, Samuel C. Haywood, Song Liu, Tao Liu, Hannelore V. Heemers

    Published in Cell Reports (2025-09-01)
    Get full text
    Article


  19. 19

    Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis by Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, Annika Böhme, Ralf Lesche, Oliver vonAhsen, Sylvia Grünewald, Holly M. Nguyen, Eva Corey, Simon J. Baumgart, Victoria Georgi, Vera Pütter, Amaury Fernández‐Montalván, James D. Vasta, Matthew B. Robers, Oliver Politz, Dominik Mumberg, Bernard Haendler

    Published in Molecular Oncology (2024-03-01)
    Get full text
    Article


  20. 20

    Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer by Larysa Poluben, Mannan Nouri, Jiaqian Liang, Shaoyong Chen, Andreas Varkaris, Betul Ersoy-Fazlioglu, Olga Voznesensky, Irene I. Lee, Xintao Qiu, Laura Cato, Ji-Heui Seo, Matthew L. Freedman, Adam G. Sowalsky, Nathan A. Lack, Eva Corey, Peter S. Nelson, Myles Brown, Henry W. Long, Joshua W. Russo, Steven P. Balk

    Published in Cell Reports (2025-01-01)
    Get full text
    Article


Search Tools: